Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit

We report the case of a 34-year-old woman affected by breast cancer that had metastasized to the bone. She had been treated with oral cyclophosphamide and methotrexate (metronomic chemotherapy) and achieved 3.5 years of clinical remission. To our knowledge, this is the first description of such a pr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Masci, G, Losurdo, A, Gandini, C, Garassino, I, di Tommaso, L, Torrisi, R, Zuradelli, M, Santoro, A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cancer Intelligence 2012
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3484813/
https://ncbi.nlm.nih.gov/pubmed/23130087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2012.275
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak